Print

Affymetrix (Santa Clara, California) (AFFX) Introduces Axiom® Biobank Arrays for Genotyping Studies  
11/1/2012 8:22:32 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today introduced Axiom® Biobank Arrays, a flexible and high-powered functional biology solution for affordably genotyping large sample collections such as those screened at biobanks, genome centers, and core labs.
//-->